Oral health in oncology: impact of immunotherapy

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

(2013) Omid Hamid et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ipilimumab and Its Toxicities: A Multidisciplinary Approach

(2013) L. A. Fecher et al.   ONCOLOGIST

Promising systemic immunotherapies in head and neck squamous cell carcinoma

(2013) Neil Gildener-Leapman et al.   ORAL ONCOLOGY

Influence of cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms in periodontitis

(2012) B. Houshmand et al.   ARCHIVES OF ORAL BIOLOGY

Evaluation of cytotoxic T-cell activation, chemokine receptors, and adhesion molecules in blood and serum in patients with oral lichen planus

(2012) Filiz Namdar Pekiner et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

(2012) Julie R. Brahmer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

(2012) Suzanne L. Topalian et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-term oral effects in patients treated with radiochemotherapy for head and neck cancer

(2012) Aline Lima da Silva Deboni et al.   SUPPORTIVE CARE IN CANCER

The high expression level of programmed death-1 ligand 2 in oral lichen planus and the possible costimulatory effect on human T cells

(2011) Guan-Huan Du et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

Pathogenesis of oral lichen planus - a review

(2010) M. R. Roopashree et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cytokine responses against periodontal infection: protective and destructive roles

(2009) Yen-Chun G. Liu et al.   PERIODONTOLOGY 2000

Oral graft-versus-host disease

(2008) MM Imanguli et al.   ORAL DISEASES